Table 2.
Treatment Outcomes.
| HAM-pegA | CLAG-M | p-Value | |
|---|---|---|---|
| Primary Endpoint | |||
| Composite complete response (CR + CRh + CRi) | 90.0% (9/10) | 47.1% (16/34) | 0.027 |
| CR | 70.0% (7/10) | 35.3% (12/34) | NS |
| CRh | 0% (0/10) | 0% (0/34) | NS |
| CRi | 20.0% (2/10) | 11.8% (4/34) | NS |
| Secondary Endpoints | |||
| Incidence of proceeding to allogeneic HSCT | 50.0% (5/10) | 26.5% (9/34) | NS |
| LOS (days)—median (range) | 30 (24–37) | 35.5 (7–106) | NS |
| 6-month re-hospitalizations—mean | 1.5 | 1.06 | NS |
| 30-day survival (%) | 100.0 | 94.1 | NS |
| 60-day survival (%) | 100.0 | 88.2 | NS |
LOS = length of stay; CRh = Complete remission with partial count recovery; CRi = Complete remission with incomplete count recovery; NS = not significant.